Vaccines

P-BIO Pledge 4 COVID - Contribution of Portuguese Biotech Start-ups

2 Abril, 2020

P-BIO, Biosurfit, CEiiA, CellmAbs, Crioestaminal, Genibet, HeartGenetics, Immunethep, LiMM, Matera, MyBiome, Nano4, Stab Vida, SWORD Health, TonicApp, MCTES

Innovative non-thermal/chemical process to generated whole attenuated virus with native-like antigen profile to produce improved vaccines

and 2 Abril, 2020

LAQV-REQUIMTE, Universidade de Aveiro

Looking for a partner able to replicate Covid-19 virus to be attenuated by the novel process and another partner to produce and test the vaccine in vitro (mammalian cells and other if considered more adequate/pertinent)

I-MOVE COVID-19: European primary care and hospital network

2 Abril, 2020

Instituto Nacional de Saúde Dr. Ricardo Jorge and Direção Geral da Saúde.

Epiconcept, France (coordinators) 

Public health Institute Albania 

Public Health England 

University of Oxford/RCGP RSC, UK 

Université Sorbonne, France 

Institut Pasteur, France 

Santé Publique France 

Université de Corse Pascal Paoli, France 

Vienna Vaccine Safety Initiative (ViVI), Germany 

HPSC, Ireland 

Lithuanian University of Health Sciences, Lithuania 

NIVEL, The Netherlands 

RIVM, The Netherlands 

INS Ricardo Jorge, Portugal 

DGS Portugal 

INCDMIC Cantacuzino, Romania 

Public Health Scotland 

ISCIII National Centre for Epidemiology, Spain 

ISCIII National Centre for Microbiology, Spain 

ISPL-Navarra, Spain 

Public Health Agency, Sweden 

dontdelete

2 Abril, 2020

Teste